GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Spire Healthcare Group PLC (LSE:SPI) » Definitions » Short Interest

Spire Healthcare Group (LSE:SPI) Short Interest


View and export this data going back to 2014. Start your Free Trial

What is Spire Healthcare Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Spire Healthcare Group's Short Interest

For the Medical Care Facilities subindustry, Spire Healthcare Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spire Healthcare Group's Short Interest Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's Short Interest distribution charts can be found below:

* The bar in red indicates where Spire Healthcare Group's Short Interest falls into.



Spire Healthcare Group (LSE:SPI) Business Description

Traded in Other Exchanges
Address
3 Dorset Rise, London, GBR, EC4Y 8EN
Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The Group is a well-located and scalable hospital have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs and Private Medical Insurance providers. It treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.